ACMA Begins Board Certification Program for Biologics, Biosimilars Specialists

American Journal of Managed Care Center for Biosimilars (12/05/22) Jeremias, Skylar

The Accreditation Council for Medical Affairs has launched a program for healthcare professionals to become Board Certified Biologics and Biosimilars Specialists (BCBBS). The program website describes it as "a self-paced, online, board certification program that strives to set the standard of excellence in the field of biologics and biosimilars, with the goal of cultivating "expertise among professionals involved in the optimization of biological therapy." ACMA said program completion takes 40 hours, and round-the-clock chat support is provided. The BCBBS program features nine learning modules and a six-month deadline to complete the course. Topics include the history of biologics; current status of and impediments to their use in the U.S.; utilizing Food and Drug Administration resources and the Purple Book; the drugs' future outlook; regulatory and economic factors; clinical guidelines and real-world cases; and international experience.

Read More